HOME >> BIOLOGY >> NEWS
MIT model could predict cells' response to drugs

CAMBRIDGE, MA, July 27MIT researchers have developed a model that could predict how cells will respond to targeted drug therapies. Models based on this approach could help doctors make better treatment choices for individual patients, who often respond differently to the same drug, and could help drug developers identify the ideal compounds on which to focus their research.

In addition, the model could help test the effectiveness of drugs for a wide range of diseases, including various kinds of cancer, arthritis and immune system disorders, according to Douglas Lauffenburger, MIT professor of biological engineering and head of the department. Lauffenburger is senior author of a paper on the new model that will appear in the Aug. 2 issue of Nature.

The model is based on similarities in the signaling pathways cells use to process information. Those pathways translate cells' environmental stimuli, such as hormones, drugs or other molecules, into action.

"Cells undertake behavioral functions-proliferation, differentiation, death-in response to stimuli in their environment," said Lauffenburger. "The signaling pathways are the biomolecular circuits that process that information from the environment and regulate the mechanisms that execute the behavorial functions."

The pathways work via a series of signals in which proteins, known as kinases, activate other cell machinery to achieve a specific result, e.g., expression of certain genes, or actions of cytoskeletal proteins. While the same stimuli can produce diverse responses in different types of cells, the researchers believe they can use the same core pathways to achieve various end results.

Lauffenburger compared a cell's strategy to playing a piano: Just as there are 88 keys that can be played in a vast number of combinations to produce different melodies, cells can use their multiple pathways together in many different combinations to produce different behaviors.'"/>

Contact: Patti Richards
prichards@mit.edu
617-253-8923
Massachusetts Institute of Technology
30-Jul-2007


Page: 1 2

Related biology news :

1. Huntingtons disease study shows animal models on target
2. Stem cell therapy rescues motor neurons in ALS model
3. Drug protects brain cells in Huntingtons disease model, researchers find
4. New model for autism suggests women carry the disorder and explains age as a risk factor
5. New treatment model for HIV
6. A first-principles model of early evolution
7. Virginia Tech researchers to study poplar tree as model biomass crop
8. Scripps research scientists show protein accelerates breast cancer progression in animal models
9. Better chemistry through living models
10. Gene therapy delivery of nerve growth factors reverses erectile dysfunction in animal model
11. New mouse model closely mimics human cancers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... SHANGHAI (PRWEB) , ... August 24, 2020 , ... ... approaches for the treatment of chronic inflammatory and fibrotic diseases, today announced that ... Vice President of Drug Discovery. , Dr. Canan previously served as Executive Director ...
(Date:8/23/2020)... THE WOODLANDS, Texas (PRWEB) , ... August 21, ... ... from Rigaku Corporation has been published and is now available ... on single crystal X-ray diffraction—serves the X-ray analysis community, presenting current news and ...
(Date:8/21/2020)... ... August 20, 2020 , ... NDA Partners Chairman ... Operations executive with expertise in clinical trial planning and feasibility, regulatory inspection readiness, ... Consultant. Throughout his career, Mr. Movahhed has helped design and manage oncology, neurology, ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... BINGHAM FARMS, Mich. (PRWEB) , ... August 12, ... ... International Consulting Group, Inc. (EMMA International), a global leader in FDA compliance ... ranking of the nation’s fastest-growing private companies. The list represents a unique look ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... R3 Stem ... injections for only $3950. With 50 million stem cells total, patients may choose which ... cell therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas Medicine, Inc. ... of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and ... a strategic partnership whereby Catalent will provide support for the development, manufacturing, and ...
(Date:7/22/2020)... , ... July 22, 2020 , ... Join experts from ... Lorenc, Sr. Manager Regulatory Solutions, in a one hour live webinar on ... regulating body in China for drugs and medical devices. Specifically, for medical devices, the ...
Breaking Biology Technology:
Cached News: